SNCA and Parkinson disease: In addition, data supporting that monomeric, oligomeric, and fibrillary α-synuclein can activate microglial cells [90–93] suggest that all these forms of the protein could affect neuronal homeostasis by modulating microglia function that could be either protective or detrimental in PD [94].